• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Lyka Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500259
INE933A01014
24.3765761
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LYKALABS
0
247.44
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Atharv Enterprises standalone net profit declines 16.67% in the March 2026 quarter
May 30,2026
Net profit of Atharv Enterprises declined 16.67% to Rs 0.05 crore in the quarter ended March 2026 as against Rs 0.06 crore during the previous quarter ended March 2025. Sales reported to Rs 0.02 crore in the quarter ended March 2026. There were no Sales reported during the previous quarter ended March 2025.

For the full year,net profit remain constant at Rs 0.19 crore in the year ended March 2026 and also during the previous year ended March 2025. Sales rose 77.78% to Rs 0.48 crore in the year ended March 2026 as against Rs 0.27 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.020 0 0.480.27 78
OPM %-6050.000 --616.67-977.78 -
PBDT0.100.09 11 0.370.30 23
PBT0.070.08 -13 0.250.25 0
NP0.050.06 -17 0.190.19 0